Identification of Micro RNAs within Chromosome 1p Minimal Deletion Region Associated Adverse Outcomes in Multiple Myeloma

被引：0
|
作者：
Yang, Y.
Ning, Y.
Chang, H.
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
[2] Univ Maryland, Baltimore, MD 21201 USA
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1600
引用
收藏
页码：382A / 382A
页数：1
相关论文
共 50 条
  • [1] Identification of Micro RNAs within Chromosome 1p Minimal Deletion Region Associated Adverse Outcomes in Multiple Myeloma
    Yang, Y.
    Ning, Y.
    Chang, H.
    LABORATORY INVESTIGATION, 2012, 92 : 382A - 382A
  • [2] Mir-137 and Mir-197 within Chromosome 1p Minimal Deletion Region Regulate Apoptotic Activity in Multiple Myeloma by Targeting MCL 1
    Yang, Yijun
    Onay, Venus
    Qi, Connie
    Saha, Manujendra N.
    Ning, Yi
    Chang, Hong
    BLOOD, 2012, 120 (21)
  • [3] Deletion 1p at Time of Diagnosis of Multiple Myeloma Portends Inferior Outcomes
    Vaishnav, Arti
    Khan, Abdullah
    Zhao, Qiuhong
    Bumma, Naresh
    Cottini, Francesca
    Umyarova, Elvira
    Sharma, Nidhi
    Rosko, Ashley E.
    Benson, Don
    Devarakonda, Srinivas
    BLOOD, 2023, 142
  • [4] Prognostic value of 1p deletion for multiple myeloma: a meta-analysis
    Ouyang, J.
    Gou, X.
    Ma, Y.
    Huang, Q.
    Jiang, T.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 (05) : 555 - 565
  • [5] Identification of a 3 cM commonly deleted region in mantle cell lymphoma with chromosome 1p deletion.
    Wlodarska, I
    Sestigiani, C
    Gasco, M
    Willis, T
    Bastard, C
    De Wolfe-Peeters, C
    Dyer, M
    Hagemeijer, A
    BLOOD, 2000, 96 (11) : 177B - 177B
  • [6] DELETION OF CDKN2C DRIVES THE PROGNOSTIC IMPACT OF DELETION 1P IN MULTIPLE MYELOMA
    Begum, D.
    Ellis, S.
    Price, A.
    Smith, C.
    Sherborne, A.
    Proszek, P.
    Johnson, D.
    Walker, B.
    Jones, J.
    Pawlyn, C.
    Jenner, M.
    Drayson, M.
    Owen, R.
    Houlston, R.
    Cairns, D.
    Gregory, W.
    Cook, G.
    Davies, F.
    Morgan, G.
    Jackson, G.
    Kaiser, M.
    HAEMATOLOGICA, 2016, 101 : 329 - 329
  • [7] Contig assembly and transcript identification in the 1p deletion syndrome region.
    Bedell, JA
    Barbazuk, WB
    Wylie, KM
    Woolley, JP
    Handa, K
    Dumars, KW
    Smith, DM
    McPherson, JD
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A231 - A231
  • [8] Outcomes of Myeloma Patients with Deletion 1p Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) Therapy
    Odikadze, Levani
    Joseph, Nisha
    Schmidt, Timothy M.
    Heffner, Leonard
    Hofmeister, Craig C.
    Dhodapkar, Madhav V.
    Gupta, Vikas A.
    Boise, Lawrence H.
    Jaye, David L.
    Lonial, Sagar
    Nooka, Ajay K.
    Kaufman, Jonathan L.
    BLOOD, 2018, 132
  • [9] Identification of characteristic and prognostic values of chromosome 1p abnormality by multi-gene fluorescence in situ hybridization in multiple myeloma
    F Li
    L Hu
    Y Xu
    Z Li
    S Yi
    Z Gu
    C Li
    M Hao
    K Ru
    F Zhan
    A Zetterberg
    W Yuan
    T Cheng
    L Qiu
    Leukemia, 2016, 30 : 1197 - 1201
  • [10] Identification of characteristic and prognostic values of chromosome 1p abnormality by multi-gene fluorescence in situ hybridization in multiple myeloma
    Li, F.
    Hu, L.
    Xu, Y.
    Li, Z.
    Yi, S.
    Gu, Z.
    Li, C.
    Hao, M.
    Ru, K.
    Zhan, F.
    Zetterberg, A.
    Yuan, W.
    Cheng, T.
    Qiu, L.
    LEUKEMIA, 2016, 30 (05) : 1197 - 1201
12345